View Older Stories View More Recent Stories

Sep 9, 2026 07:00AM Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers
Aug 6, 2026 08:09AM MBX (MBX) Reports Q2 Loss of $0.78
Jul 13, 2026 04:15PM MBX Biosciences names new CEO and CFO amid leadership shift
Jun 12, 2026 07:01AM MBX Biosciences reports sustained one-year data for weekly drug trial
May 12, 2026 05:37AM MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
May 11, 2026 04:22PM MBX Biosciences Inc (MBX) PT Raised to $56 at Stifel
May 7, 2026 08:33AM MBX (MBX) Reports Q1 Loss of $0.51
May 4, 2026 08:19AM Oppenheimer Assumes MBX Biosciences Inc (MBX) at Outperform
Apr 23, 2026 09:47AM Truist Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Apr 13, 2026 12:27PM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX), eyes MBX-4291 GLP Ph.1/2a trial results in Q4
Mar 13, 2026 06:25AM MBX Biosciences (MBX) Reiterated at Market Outperform by Citizens: Among Top '26 Picks
Mar 12, 2026 04:01PM Truist on MBX Biosciences Inc (MBX): 'We remain buyers'
Mar 12, 2026 04:00PM Truist Securities Reiterates Buy Rating on MBX Biosciences Inc (MBX): "We remain buyers of MBX following 4Q25 earnings"
Mar 12, 2026 03:56PM MBX (MBX) Reports Q4 Loss of $0.49
Mar 12, 2026 12:50PM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX): "operating flexibility to reach multiple value-creating events this year"
Mar 12, 2026 11:30AM TD Cowen Reiterates Buy Rating on MBX Biosciences Inc (MBX): "confident" that canvu Phase III will be successful
Mar 10, 2026 08:03AM MBX Biosciences names Karen Basbaum as chief business officer
Mar 9, 2026 08:57AM Truist Securities Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Feb 24, 2026 10:25AM UBS Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Jan 16, 2026 06:36AM MBX Biosciences Inc (MBX) PT Raised to $88 at Guggenheim
Jan 13, 2026 07:22AM MBX Biosciences (MBX) Reiterated at Buy by Stifel: Advancing Obesity Portfolio
Jan 12, 2026 06:05AM MBX Biosciences to present pipeline updates at JP Morgan conference
Jan 7, 2026 12:44AM UBS Starts MBX Biosciences Inc (MBX) at Buy
Dec 19, 2025 07:38AM MBX Biosciences Inc (MBX) PT Raised to $50 at Stifel on PEP Platform Validation
Dec 4, 2025 06:51AM Goldman Sachs Starts MBX Biosciences Inc (MBX) at Sell
Nov 20, 2025 04:01AM Jefferies Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Nov 6, 2025 04:32PM MBX (MBX) Reports Q3 Loss of $0.63
Nov 4, 2025 05:34AM TD Cowen Starts MBX Biosciences Inc (MBX) at Buy
Oct 15, 2025 06:52AM Oppenheimer Reiterates Outperform Rating on MBX Biosciences Inc (MBX)
Oct 14, 2025 04:02PM Truist Securities Starts MBX Biosciences Inc (MBX) at Buy
Oct 8, 2025 07:00AM Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates
Oct 7, 2025 07:55AM Citizens sees blockbuster potential in MBX Biosciences (MBX) post phase 2 data
Sep 24, 2025 06:35AM MBX Biosciences Inc (MBX) PT Raised to $56 at Mizuho
Sep 23, 2025 06:43AM MBX Biosciences Inc (MBX) PT Raised to $84 at Guggenheim
Sep 22, 2025 04:13PM MBX Biosciences (MBX) files for 10M share offering
Sep 22, 2025 06:56AM MBX Biosciences (MBX) Halted, News Pending
Aug 15, 2025 05:16AM Jefferies Assumes MBX Biosciences Inc (MBX) at Buy
Aug 5, 2025 05:14AM Mizuho Starts MBX Biosciences Inc (MBX) at Outperform
Jul 23, 2025 06:21AM Oppenheimer Reiterates Outperform Rating on MBX Biosciences Inc (MBX)
Jul 16, 2025 06:02AM Oppenheimer Starts MBX Biosciences Inc (MBX) at Outperform
Jul 16, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)
Jul 2, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)
Jun 24, 2025 09:17AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Jun 16, 2025 08:03AM MBX Biosciences (MBX) Announces IND Submission of MBX 4291
Jun 12, 2025 07:13AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX)
May 13, 2025 06:30AM MBX (MBX) Reports Q1 Loss of $0.71
May 12, 2025 11:42AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX), PT $40, 'MBX has comfortable runway into mid-2027, well past the key AVAIL readout'
Apr 23, 2025 04:22AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)
Apr 10, 2025 03:12AM Citizens JMP Starts MBX Biosciences Inc (MBX) at Market Outperform
Apr 7, 2025 08:02AM MBX Biosciences (MBX) Appoints Steve Hoerter to its Board
View More Recent Stories View Older Stories